Ebselen not checked

Sound Pharmaceuticals, Incorporated · SPI-1005

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
3 active
11 in total

What this is

How it works
How it works isn't classified yet
Tested for
Meniere's Disease, Ménière's Disease, Covid19, Corona Virus Infection, Coronavirus, Coronavirus Infection, Hearing Loss, Cochlear Trauma
Main trialPhase 3
“Study of the safety of open-label SPI-1005 400 mg BID treatment in adults with Meniere's Disease (MD) for 6 or 12 months to support chronic or chronic intermittent use.”In the company’s words, NCT06859788 on ClinicalTrials.gov
Other names
SPI-1005 · Low Dose

Other drugs for Covid19

All 44 drugs for Covid19

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials11

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting Dec 2026 SPI-1005 for the Treatment of Meniere's Disease (Open Label)
Phase 2Enrolling by invitation 31 Dec 2023 SPI-1005 Treatment in Moderate COVID-19 Patients
Phase 2Recruiting Dec 2026 SPI-1005 in Adults Receiving Cochlear Implant
Phase 3Completed 19 Sep 2023 SPI-1005 for the Treatment of Meniere's Disease
Phase 2Completed Dec 2013 Otoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
Phase 2Completed 30 Apr 2019 SPI-1005 for the Treatment of Patients With Meniere's Disease
Phase 2Completed 7 Apr 2023 SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Phase 2Completed 5 May 2023 SPI-1005 Treatment in Severe COVID-19 Patients
Phase 2Withdrawn Jun 2026 SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Phase 2Withdrawn Jun 2026 A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
Phase 1/2Completed Aug 2017 Study to Evaluate SPI-1005 in Adults With Meniere's Disease
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Ebselen

Following is part of Solo: you see every change to Ebselen the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in